Medications

30 years on, are we winning the fight against Alzheimer's?

UC San Francisco experts say that we have reached a pivotal point in Alzheimer's disease research, 30 years after the first pharmaceutical came to market. On Jan. 6, 2023, the Food and Drug Administration is expected to give ...

Neuroscience

Eye movement science is helping us learn about how we think

For most of human history if you wanted to know what was going on behind someone's eyes you had to make your best guess. But since the 1960s scientists have been studying the way eye movements may help decode people's thoughts. ...

Neuroscience

Study: Antioxidant flavonols linked to slower memory decline

People who eat or drink more foods with antioxidant flavonols, which are found in several fruits and vegetables as well as tea and wine, may have a slower rate of memory decline, according to a study published in Neurology.

Neuroscience

Stroke patients with delirium may struggle more during recovery

Every year approximately 9,000 people are admitted to hospital with stroke in Norway. Some of those who have a stroke also experience a temporary state of acute confusion. This condition is called delirium and often occurs ...

Diseases, Conditions, Syndromes

What is, and what isn't, 'brain fog?'

The COVID pandemic has introduced many scientific and medical terms into our everyday language. Many of us are now fluent in conversations about viral strains, PCR tests and mortality rates. "Brain fog" has joined these ranks ...

Neuroscience

New study expands range of potential Alzheimer's drugs

Alzheimer's disease is associated with a reduction of insulin receptors in brain microvessels, which may contribute to brain insulin resistance and the formation of amyloid plaques, one of the disease's hallmarks. That's ...

page 6 from 40